Bethanechol
- Generic Name
- Bethanechol
- Brand Names
- Duvoid
- Drug Type
- Small Molecule
- Chemical Formula
- C7H17N2O2
- CAS Number
- 674-38-4
- Unique Ingredient Identifier
- 004F72P8F4
- Background
Bethanechol is a synthetic ester that was initially synthesized in 1935. As a cholinergic agent, bethanechol is similar in structure and pharmacological function to acetylcholine and is used in specific cases when stimulation of the parasympathetic nervous system is necessary. For example, bethanechol is readily used to treat postoperative or postpartum urin...
- Indication
Bethanechol is indicated for the treatment of acute, functional postpartum and postoperative urinary retention. It is also indicated for the treatment of neurogenic atony of the bladder with retention.
- Associated Conditions
- Acute post-operative Urinary retention, Neurogenic atony of the urinary bladder, Non-obstructive postpartum urinary retention
- Associated Therapies
- -
The Effect of Bethanechol on Tracheobronchomalacia
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Arkansas Children's Hospital Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT05299008
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2022-02-15
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Susan E. Bates
- Target Recruit Count
- 37
- Registration Number
- NCT05241249
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Bethanechol Prior to Pancreatic Surgery
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 17
- Registration Number
- NCT03572283
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Bethanechol for Eosinophilic Esophagitis
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 2
- Registration Number
- NCT02058537
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Topical Bethanechol for Improvement of Esophageal Dysmotility
- First Posted Date
- 2009-12-14
- Last Posted Date
- 2015-01-29
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 5
- Registration Number
- NCT01031043
- Locations
- 🇺🇸
Medical College of Georgia, Augusta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.